Kangbuk Samsung Hospital
Seoul, 110-746, South Korea
NCT Number: NCT03438890
The aim of this study is to compare three popular methods of minimizing or reducing laparoscopic lens fogging (LLF) by heating lens using warm saline, applying anti-fog agent to lens, and rubbing lens with chlorhexidine in laparoscopic gynecologic surgery.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Seoul, 110-746, South Korea
The physiology behind laparoscopic lens fogging (LLF) is well understood based on meticulous experiments outlining the role of temperature and humidity. Despite many efforts, including uses of warm saline, various anti-fog agents, chlorhexidine, betadine, and rubbing the lens on serosal surfaces, to reduce LLF, there remains no consensus as to which method is superior to prevent LLF. Furthermore, most previous studies were experimental trials conducted in a simulation model or a non-human in vivo model or an expert's commentary based on their clinical experiences , and there was no randomized controlled trial focusing LLF in human model. Therefore, this randomized trial aimed to compare three popular methods of minimizing or reducing LLF by heating lens using warm saline, applying anti-fog agent to lens, and rubbing lens with chlorhexidine in laparoscopic gynecologic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In subjects allocated to the warm saline group, a thermos flask, which was filled with heated sterile water, was used. A 1000 ml bottle of sterile water was heated to 60 ˚C in a stove for an hour at minimum. Just before introducing into the abdominal cavity, the laparoscope was placed into the thermos flask for 30 seconds at minimum . After each incidence of laparoscopic lens fogging (LLF), the scope was briefly inserted into the thermos flask about 10 seconds, and was then wrapped gauze around the lens before abdominal reinsertion.
In the anti-fog agent group, Ultra-Stop TM (Sigmaphrarm, Vienna, Austria), which is a commercial anti-fogging solution containing alcohol, surfactant, and water for medical optical devices, was used. Wiping the lens with gauze soaked in Ultra-Stop TM and allowing the surfactant to act for 5 seconds, the laparoscope was introduced into the abdominal cavity. After each laparoscopic lens fogging (LLF), the scope was removed from the abdomen and cleaned using the same corresponding method.
In the chlorhexidine group, the lens was wiped with gauze soaked in 4% chlorhexidine detergent solution (Firson, Cheonan, Korea) for 5 seconds before introducing into the abdominal cavity, and chlorhexidine was reapplied on the lens at the occurrence of laparoscopic lens fogging (LLF).
Time frame: At the time of surgery
The severity of LLF was rated on a scale of 0 (the clearest) to 10 (the foggiest).
Time frame: At the time of surgery
The severity of LLF was rated on a scale of 0 (the clearest) to 10 (the foggiest).
Time frame: At the time of surgery
We will assess the number of lens cleansing at the time of surgery.
Time frame: At the time of surgery
We will assess the total time to spend for lens cleansing at the time of surgery.
Kangbuk Samsung Hospital
Other
Randomized Comparison of Laparoscopic LEns Defogging Using Anti-fog Solution, waRm Saline, and Chlorhexidine Solution (CLEAR)
Acronym: CLEAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06875518
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Damietta, New Damietta, Egypt
View Trial DetailsNCT07292324
Chronic Post Surgical Pain, Female Urogenital Diseases
Denpasar, Bali, Indonesia
View Trial DetailsNCT05897385
Agnosia, Female Urogenital Diseases
Kuala Lumpur, Malaysia
View Trial DetailsNCT06536192
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Karabük, Karabük Province, Turkey (Türkiye)
View Trial Details